ONDANSETRON | SANDOZ | ||
4MG,8MG | |||
Yes | No | ||
2016-May-14 | Expired | ||
None | None | ||
None | No | ||
ZOFRAN is a 5-HT3 receptor antagonist indicated for the prevention of: • nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2. • nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. • nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. • postoperative nausea and/or vomiting. |
8 | 0 | 6 |
Total Other Developers | None |
---|
Drugs with Suitability | Yes |
---|
4MG | ** | ** | - | - | 4 |
8MG | ** | ** | - | - | 4 |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 5 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|---|---|---|---|---|
****** | ********* ********* | ********* *************** *******, ***. | *********** | ** ******* *****, *** ***** ******, *******, *** **** (**) *****, ****** ****** (***) | *** |
****** | *** ***** **** | *** ************** ********** ******* | *********** | *****-****** *******, *****, ******* ******, ***** (***) | *** |
****** | ****** | ****** ******* ******* | *********** | **** **. *-*/* *** *-*, *** ********** **** ***** *****, ******* *****, **** ******, *********** ******, ***** (***) | *** |
****** | ******** ****** *** | ******** *************** ******* | *********** | **** ** *-*, ******* ********** ******, *******-******,, ***, ** ******, ***** (***) | *** |
****** | ******** ****** *** | ******** *************** ******* | *********** | **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) | *** |
****** | ********* ****** | ********* ****** ******* | *********** | ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) | *** |
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com